Stocks
Arrowhead Pharmaceuticals, Inc.ARWR
NASDAQHealthcareBiotechnology$55.05+0.07%
A clinical-stage biotechnology company developing RNA interference (RNAi) therapies designed to silence disease-causing genes. Its pipeline focuses on cardiometabolic, pulmonary, and liver-related disorders, with multiple candidates in clinical development and partnerships with large pharmaceutical ...
Market Cap: $7.7B52W Range: $9.57 – $76.76
Congressional Interest in Arrowhead Pharmaceuticals, Inc. (ARWR)
1 member of Congress has disclosed 1 trade in Arrowhead Pharmaceuticals, Inc. (ARWR), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ARWR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-01-31 | Daniel Goldman | sell | $1K – $15K |